Seegene Inc (096530.KQ) stock: key figures, P/E, revenue and dividend

Health Care · Biotechnology · South Korea · ISIN KR7096530001

Price
33,250.00 KRW
Market cap
1.51 tn KRW
P/E (2025)
31.38
P/S (2025)
3.19
Dividend yield
3.01 %
Net margin
10.18 %
Return on equity (ROE)
4.75 %
Return on assets (ROA)
3.91 %

Seegene Inc financials

Fiscal year20242025
Revenue414.25 bn KRW474.23 bn KRW
Gross profit238.62 bn KRW303.86 bn KRW
Operating income-44.44 bn KRW34.55 bn KRW
EBIT-3.63 bn KRW60.90 bn KRW
Net income-20.34 bn KRW48.27 bn KRW
Diluted EPS – continuing operations-440.31 KRW1,059.68 KRW

Full history since 2012, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Seegene Inc

Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis detection products. The company also provides other products for the detection of SNPs in factor II, factor V, and MTHFR genes. The company has a collaboration with Werfen for the joint development of syndromic qPCR assays. Seegene, Inc. was founded in 2000 and is headquartered in Seoul, South Korea.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.